BioCentury | Feb 10, 2017
Company News

Perthera, Novartis deal

...financial terms. Perthera Inc. , McLean, Va. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Cancer Nora Weintraub Novartis AG Perthera Inc....
BioCentury | Sep 22, 2016
Translation in Brief

Precision traffic control

...Following its July $8.7 million series A funding round, Perthera Inc. is building up its precision medicine...
...to expert guidance on which tests to order and how to interpret results. Emanuel Petricoin, Perthera's...
...Perthera enters a clinical trial. The series A funding and the current fees should help Perthera...
BioCentury | Jul 11, 2016
Financial News

Perthera completes venture financing

Perthera Inc. , McLean, Va. Business: Supply/Service, Cancer Date completed: 2016-06-28 Type: Venture financing Raised: $8.7 million Investor: Pilot Growth Equity WIR Staff cancer...
BioCentury | Mar 6, 2015
Company News

Management tracks

...counsel, a newly created position. Stahl was SVP and general counsel at Idenix Pharmaceuticals Inc. Perthera Inc....
BioCentury | Mar 10, 2014
Company News

Perthera management update

Personalized Cancer Therapy Inc. , McLean, Va. Business: Diagnostic, Supply/Service Hired: Subha Madhavan as chief data officer, currently director of the Innovation Center for Biomedical Informatics (ICBI) at the Georgetown University Medical Center WIR Staff cancer...
BioCentury | Dec 9, 2013
Company News

Perthera sales and marketing update

...Newco Perthera debuted with its personalized cancer treatment service. The company's service includes tissue collection, multiplex...
...includes tissue collection, multiplex molecular profiling and an analysis of a patient's unique cancer. Perthera's Perthera...
...medical review panel comprised of a disease-specific expert and board-certified oncologists who make treatment recommendations. Perthera Inc....
Items per page:
1 - 6 of 6
BioCentury | Feb 10, 2017
Company News

Perthera, Novartis deal

...financial terms. Perthera Inc. , McLean, Va. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Cancer Nora Weintraub Novartis AG Perthera Inc....
BioCentury | Sep 22, 2016
Translation in Brief

Precision traffic control

...Following its July $8.7 million series A funding round, Perthera Inc. is building up its precision medicine...
...to expert guidance on which tests to order and how to interpret results. Emanuel Petricoin, Perthera's...
...Perthera enters a clinical trial. The series A funding and the current fees should help Perthera...
BioCentury | Jul 11, 2016
Financial News

Perthera completes venture financing

Perthera Inc. , McLean, Va. Business: Supply/Service, Cancer Date completed: 2016-06-28 Type: Venture financing Raised: $8.7 million Investor: Pilot Growth Equity WIR Staff cancer...
BioCentury | Mar 6, 2015
Company News

Management tracks

...counsel, a newly created position. Stahl was SVP and general counsel at Idenix Pharmaceuticals Inc. Perthera Inc....
BioCentury | Mar 10, 2014
Company News

Perthera management update

Personalized Cancer Therapy Inc. , McLean, Va. Business: Diagnostic, Supply/Service Hired: Subha Madhavan as chief data officer, currently director of the Innovation Center for Biomedical Informatics (ICBI) at the Georgetown University Medical Center WIR Staff cancer...
BioCentury | Dec 9, 2013
Company News

Perthera sales and marketing update

...Newco Perthera debuted with its personalized cancer treatment service. The company's service includes tissue collection, multiplex...
...includes tissue collection, multiplex molecular profiling and an analysis of a patient's unique cancer. Perthera's Perthera...
...medical review panel comprised of a disease-specific expert and board-certified oncologists who make treatment recommendations. Perthera Inc....
Items per page:
1 - 6 of 6